{ "schema_version": 1, "title": "Repro: Coupled Training with Privileged Information and Unlabeled Data", "emoji": "microscope", "space_id": "snaykey/repro-coupled-privileged-training", "paper": { "openreview_id": "WlCYSqjnqS" }, "tags": [ "icml2026-repro", "paper-WlCYSqjnqS" ], "updated_at": "2026-07-27T00:00:00+00:00", "root": { "slug": "index", "title": "Repro: Coupled Training with Privileged Information and Unlabeled Data", "file": "pages/index.md", "children": [ { "slug": "executive-summary", "title": "Executive summary", "file": "pages/executive-summary/page.md", "children": [] }, { "slug": "claim-1", "title": "The coupled training framework jointly optimizes a deployment model using only test-time features X and a rich-view model using both X and privileged features W, with population minimizers characterized via fixed-point equations interpolating between the deployment target μ(x) and rich-view regression function η(z) (Theorem 2.1).", "file": "pages/claim-1/page.md", "children": [] }, { "slug": "claim-2", "title": "The risk bound depends on a correlation coefficient ρ* measuring alignment between deployment and rich-view estimation errors, and the method provably never performs worse than supervised learning on labeled data alone when ρ* is large (Corollary 2.3, Theorem 2.7).", "file": "pages/claim-2/page.md", "children": [] }, { "slug": "claim-3", "title": "An alternating forward selection procedure for the high-dimensional extension is proven to achieve sublinear decay of the empirical objective with O(N(|D_f|+|D_g|)k) time complexity (Theorem 3.1).", "file": "pages/claim-3/page.md", "children": [] }, { "slug": "claim-4", "title": "On Parkinson's telemonitoring regression, coupled training achieves test MSE of 72.60 versus 77.34 for the baseline using voice measurements with spectral features as privileged information (Table 1).", "file": "pages/claim-4/page.md", "children": [] }, { "slug": "claim-5", "title": "On Bank Marketing classification, coupled training attains mean Brier score 0.0881, outperforming Baseline (0.0893), Two-Stage pseudo-labeling (0.0928), and SVM+ (0.1470), winning in 26 of 26 random seeds against Two-Stage (Table 1).", "file": "pages/claim-5/page.md", "children": [] }, { "slug": "conclusion", "title": "Conclusion", "file": "pages/conclusion/page.md", "children": [] } ] } }